Tofacitinib and risk of malignancy: results from the safety of tofacitinib in routine care patients with rheumatoid arthritis (STAR‐RA) study

F Khosrow‐Khavar, RJ Desai, H Lee… - Arthritis & …, 2022 - Wiley Online Library
Objectives Results of the ORAL Surveillance safety trial have indicated that there is an
increased risk for the development of malignancies with tofacitinib therapy when compared …
被引用次数：47 相关文章

Tofacitinib and Risk of Malignancy: Results From the Safety of Tofacitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA) Study

F Khosrow-Khavar, RJ Desai, H Lee, SB Lee, SC Kim - 2022 - pubmed.ncbi.nlm.nih.gov
Objectives Results of the ORAL Surveillance safety trial have indicated that there is an
increased risk for the development of malignancies with tofacitinib therapy when compared …
[HTML] nih.gov

[HTML][HTML] Tofacitinib and risk of malignancy: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) Study

F Khosrow-Khavar, RJ Desai, H Lee… - Arthritis & …, 2022 - ncbi.nlm.nih.gov
Methods: Using US insurance claims data from Optum Clinformatics (2012–2020), IBM
MarketScan (2012–2018), and Medicare (parts A, B, D, 2012–2017), we created two cohorts …

Tofacitinib and Risk of Malignancy: Results From the Safety of Tofacitinib in Routine Care Patients With Rheumatoid Arthritis (STAR‐RA) Study.

F Khosrow‐Khavar, RJ Desai, H Lee… - Arthritis & …, 2022 - search.ebscohost.com
Objectives: Results of the ORAL Surveillance safety trial have indicated that there is an
increased risk for the development of malignancies with tofacitinib therapy when compared …

Tofacitinib and Risk of Malignancy: Results From the Safety of Tofacitinib in Routine Care Patients With Rheumatoid Arthritis (STAR‐RA) Study

F Khosrow‐Khavar, RJ Desai, H Lee… - Arthritis & …, 2022 - Wiley Online Library
Objectives Results of the ORAL Surveillance safety trial have indicated that there is an
increased risk for the development of malignancies with tofacitinib therapy when compared …

Tofacitinib and Risk of Malignancy: Results From the Safety of Tofacitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA) Study.

F Khosrow-Khavar, RJ Desai, H Lee… - Arthritis & …, 2022 - europepmc.org
Objectives Results of the ORAL Surveillance safety trial have indicated that there is an
increased risk for the development of malignancies with tofacitinib therapy when compared …